Search Results - "Hana, V."

Refine Results
  1. 1
  2. 2

    A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues by Franck, S E, Korevaar, T I M, Petrossians, P, Daly, A F, Chanson, P, Jaffrain-Réa, M L, Brue, T, Stalla, G K, Carvalho, D, Colao, A, Hána, V, Delemer, B, Fajardo, C, van der Lely, A J, Beckers, A, Neggers, S J C M M

    Published in European journal of endocrinology (01-04-2017)
    “…Background Effective treatment of acromegaly with pegvisomant (PEGV), a growth hormone receptor antagonist, requires an appropriate dose titration. PEGV doses…”
    Get full text
    Journal Article Web Resource
  3. 3

    Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database by Amodru, V., Petrossians, P., Colao, A., Delemer, B., Maione, L., Neggers, S.J.C.M.M., Decoudier, B., Kamenicky, P., Castinetti, F., Hana, V., Pivonello, R., Carvalho, D., Brue, T., Beckers, A., Chanson, P., Cuny, T.

    Published in Endocrine (01-10-2020)
    “…Purpose Acromegaly is a rare disease due to growth hormone (GH)-secreting pituitary adenoma. GH and IGF-1 levels are usually congruent, indicating either…”
    Get full text
    Journal Article Web Resource
  4. 4

    Prediction of adrenocortical insufficiency after pituitary adenoma surgery using postoperative basal cortisol levels by Hána, Jr, V, JeŽková, J, Kosák, M, Kršek, M, Marek, J, Netuka, D, Hill, M, Hána, V

    Published in Physiological research (01-01-2015)
    “…Our aim was to analyze the correlation of early postoperative cortisol levels in patients after transsphenoidal pituitary adenoma surgery compared to the…”
    Get full text
    Journal Article
  5. 5

    Can the gold standard be beaten? How reliable are various modifications of the Synacthen test compared to the insulin tolerance test by Kosak, M, Duskova, M, Starka, L, Jandikova, H, Pospisilova, H, Sramkova, M, Hana, V, Krsek, M, Springer, D, Simunkova, K

    Published in Physiological research (01-01-2017)
    “…Criteria for the evaluation of the insulin tolerance test (ITT) and Synacthen test are still a matter of debate. The objective of the study was to make a…”
    Get full text
    Journal Article
  6. 6

    Serum cortisol seems to be a more appropriate marker for adrenocortical reserve evaluation in ACTH test in comparison to salivary cortisol by Kosák, M, Hána, V, Hill, M, Simůnková, K, Lacinová, Z, Kršek, M, Marek, J

    Published in Physiological research (01-01-2014)
    “…Salivary cortisol reflects the free fraction of serum cortisol. Monitoring salivary cortisol may be a promising alternative method for assessing serum cortisol…”
    Get full text
    Journal Article
  7. 7

    Czech Tractors, Cuban Oranges: An Outline of Economic Relations between Socialist Czechoslovakia and Revolutionary Cuba by Bortlova, Hana V

    “…This work deals with the economic relations between Cuba and social- ist Czechoslovakia from the early years of the Cuban Revolution until the fall of the…”
    Get full text
    Journal Article
  8. 8

    The possible role of mRNA expression changes of GH/IGF-1/insulin axis components in subcutaneous adipose tissue in metabolic disturbances of patients with acromegaly by Touskova, V, Klouckova, J, Durovcova, V, Lacinova, Z, Kavalkova, P, Trachta, P, Kosak, M, Mraz, M, Haluzikova, D, Hana, V, Marek, J, Krsek, M, Haluzik, M

    Published in Physiological research (01-01-2016)
    “…We explored the effect of chronically elevated circulating levels of growth hormone (GH)/insulin-like-growth-factor-1 (IGF-1) on mRNA expression of…”
    Get full text
    Journal Article
  9. 9

    Drug-eluting stents in bifurcation lesions: To stent one branch or both? by Assali, Abid R., Assa, Hana V., Ben-Dor, Itsik, Teplitsky, Igal, Solodky, Alejandro, Brosh, David, Fuchs, Shmuel, Kornowski, Ran

    “…Objectives: The objective of this study was to compare two techniques to treat bifurcation lesions: a single drug‐eluting stent (DES) implanted in the main…”
    Get full text
    Journal Article
  10. 10

    Recurrent ACTH‐independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone by Hána, V., Dokoupilová, M., Marek, J., Plavka, R.

    Published in Clinical endocrinology (Oxford) (01-02-2001)
    “…A 17‐year‐old primigravid woman presented with Cushing's syndrome. Typical clinical symptoms and signs developed at the beginning of pregnancy. By week 17 of…”
    Get full text
    Journal Article
  11. 11

    Response of cortisol metabolites in the insulin tolerance test and Synacthen tests by Simunkova, K, Duskova, M, Kosak, M, Krsek, M, Hana, V, Hill, M, Jandikova, H, Pospisilova, H, Sramkova, M, Bifulco, E, Starka, L

    Published in Physiological research (01-01-2015)
    “…Determination of response of cortisol and its metabolites to different stimuli may be important for adrenal gland disorders. To date, only one metabolite,…”
    Get full text
    Journal Article
  12. 12

    Hypothalamo-pituitary dysfunction in patients with chronic subdural hematoma by Hána, V, Kosák, M, Masopust, V, Netuka, D, Lacinová, Z, Kršek, M, Marek, J, Pecen, L

    Published in Physiological research (01-01-2012)
    “…Relatively frequent pituitary hormone deficiencies are observed after traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) and according to the…”
    Get full text
    Journal Article
  13. 13

    Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement by Hana, V, Prazny, M, Marek, J, Skrha, J, Justova, V

    Published in European journal of endocrinology (01-09-2002)
    “…BACKGROUND: An increased cardiovascular risk and mortality in hypopituitary patients receiving conventional hormonal treatment without GH replacement have been…”
    Get full text
    Journal Article
  14. 14

    Novel Mutation (T273R) in Thyroid Hormone Receptor β Gene Provides Further Insight into Cryptic Negative Regulation by Thyroid Hormone by Kaššák, F, Hána, V, Saudek, V, Kostrouchová, M

    Published in Folia biologica (2017)
    “…Production of thyroid hormone is precisely regulated in a negative feed-back mechanism that depends critically on thyroid hormone receptor β (TRβ). This…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide by Marek, J, Hána, V, Krsek, M, Justová, V, Catus, F, Thomas, F

    Published in European journal of endocrinology (01-07-1994)
    “…Thirteen patients with active acromegaly despite previous surgery were treated with 30 mg lanreotide im twice a month for 9 months. In 10 subjects the…”
    Get more information
    Journal Article
  18. 18

    The contribution of X-chromosome genomic imprinting to the bicuspid aortic valve and aortic coarctation prevalence in women with Turner syndrome by Klaskova, E, Vrtel, P, Vrtel, R, Adamova, K, Vrbicka, D.I.T.A, Zapletalova, J, Prochazka, M, Pavlicek, J, Lebl, J, Stara, V, Soucek, O, Snajderova, M, Hana, V

    Published in European heart journal (01-11-2020)
    “…Abstract Introduction Turner syndrome (TS) is caused by the absence or structural abnormality of X chromosome. Compared with the general population, the…”
    Get full text
    Journal Article
  19. 19

    Interdependence of epidermal growth factor and insulin-like growth factor-I expression in the mouse uterus by Hana, V, Murphy, L J

    Published in Endocrinology (Philadelphia) (01-07-1994)
    “…Both epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) have been implicated as paracrine mediators of estrogen action in the rodent…”
    Get more information
    Journal Article
  20. 20

    Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome by Ďurovcová, V, Marek, J, Hána, V, Matoulek, M, Zikán, V, Haluzíková, D, Kaválková, P, Lacinová, Z, Krsek, M, Haluzík, M

    Published in Physiological research (01-01-2010)
    “…The objective of this study was to measure plasma fibroblast growth factor 21 and 19 (FGF21 and FGF19) levels in patients with Cushing's syndrome (CS) and to…”
    Get full text
    Journal Article